Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Asset Writedowns and Impairment (2018 - 2025)

Dna X (SONM) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $3.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $3.3 million, compared with a TTM value of $6.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $6.5 million, changed N/A over the prior year.
  • Asset Writedowns and Impairment was $3.3 million for Q4 2024 at Dna X, up from $3.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $3.3 million in Q4 2024 and bottomed at -$118000.0 in Q2 2020.
  • Average Asset Writedowns and Impairment over 4 years is $900333.3, with a median of $407000.0 recorded in 2020.
  • The sharpest move saw Asset Writedowns and Impairment surged 13666.67% in 2020, then tumbled 98.35% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at $413000.0 in 2020, then tumbled by 55.93% to $182000.0 in 2021, then crashed by 98.35% to $3000.0 in 2022, then surged by 108800.0% to $3.3 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for SONM at $3.3 million in Q4 2024, $3.2 million in Q2 2024, and $3000.0 in Q4 2022.